The three-way comparison of semaglutide, tirzepatide, and retatrutide provides a current overview of the leading candidates
Serious risks include: Thyroid tumors (including cancer) Gastroparesis (stomach paralysis) Pancreatitis Gallbladder issues Hypoglycemia (especially with type 2 diabetes) Kidney failure Serious allergic reactions Vision changes Increased heart rate Depression or suicidal thoughts Common side effects: nausea, diarrhea, vomiting, constipation, stomach pain, headache, tiredness, indigestion, bloating, belching, heartburn, and upper respiratory symptoms
The Dual-Action Mechanism of Tirzepatide Tirzepatide activates both GLP-1 and GIP receptors simultaneously, creating a dual-hormone effect that researchers call a GLP-1/GIP receptor agonist
Oh yea, the price for this product is very, very affordable
Most users see initial results within the first 4-6 weeks, with steady progress afterward